About

ARx, LLC., was founded in 2005, as a wholly owned cGMP subsidiary of Adhesives Research Inc.

Leveraging 60 years in polymer science and production technologies through our parent company, ARx, LLC., improves the outcomes for patients over traditional drug delivery systems, as a global leader in the development and manufacture of specialty pharmaceutical drug products, including oral and mucosal thin films and transdermal patches. We partner with both generic and branded drug companies to launch FDA approved prescription drug products that offer tailored drug usage and delivery, positive patient experiences, and market differentiation, while priding ourselves on being a true partner.

We partner with our customers from product ideation to commercial drug manufacturing. This includes pre-formulation, drug development and formulation, in-vitro permeation testing, analytical method development & validation, clinical unit production, process development, registration production, CMC filing support, and product validation. The ARx team leverages our foundation knowledge in dissolvable thin films and transdermal patches to ensure success at each step of the process.